Nirupama Ramadas; Erica Sparkenbaugh/LinkedIn
Nov 3, 2025, 04:56
Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
RPTH Journal shared on LinkedIn:
”Sickle cell disease (SCD) is more than a hemoglobinopathy, it’s a chronic thrombo-inflammatory disorder.
This review from Nirupama Ramadas and Erica Sparkenbaugh explores how hemolysis, endothelial activation, and cellular aggregates drive thrombosis, organ injury, and inflammation, and what that means for future therapies.
Read more.”
Read the full article in RPTH.
Article: Emerging pathways in thromboinflammation of sickle cell disease: novel findings in disease pathogenesis
Authors: Nirupama Ramadas, Erica Sparkenbaugh
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge
-
Sep 29, 2026, 16:18Edward Lee Carter: Why Periprocedural DOAC Guidance Needs a Common Output Standard
-
Sep 29, 2026, 16:07Yasmine Laraba: Deep Vein Thrombosis Causes, Signs and Management
-
Sep 29, 2026, 16:01Stephen Cornelissen: How Joining the Stem Cell Registry Can Save Patients with Blood Cancers
-
Sep 29, 2026, 15:45Alan Nurden: Could Mast Cell aIIb Integrin Play a Key Role in Septic Thrombus Stability?
-
Sep 29, 2026, 15:43Priyadarshani Sharma: Advocacy and Patient Rights Transform Indian Haemoglobinopathies Care
-
Sep 29, 2026, 15:21Kanchan K Banerjee: Rusfertide Earns NCCN Category 1 Recommendation for Polycythemia Vera
-
Sep 29, 2026, 15:06Faizan Khan։ The Worldwide Burden of Venous Thromboembolism
-
Sep 29, 2026, 14:59Global Von Willebrand Disease Diversity Webinar Now Available on EHC YouTube – EHC